Todd M. Baughman - Concepedia

Author

Todd M. Baughman

GlaxoSmithKline (United States)

Also Known As

Baughman, Todd M., T M Baughman, T.M. Baughman, Todd Baughman, Todd M. Baughman

Publications

733

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United States)Research Triangle Park Foundation Eli Lilly (United States)

About

Todd M. Baughman is an author at GlaxoSmithKline (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	632
2	Biochemistry	3	3	453
3	Natural Sciences	2	2	367
4	Health Sciences	1	1	10
5	Social Sciences	1	1	85

Todd M. Baughman

Publications

733

Citations

H-Index

Page 1

	Year	Citations
Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979. Anne H. Dantzig, Robert L. Shepard, Jin Cao, PubMed Pharmaceutical SciencePharmacotherapyChemical BiologyPharmaceutical ChemistryTumor Biology	1996	327
Pharmacological characterization of LY335979: A potent cyclopropyldibenzosuberane modulator of P-glycoprotein James J. Starling, Robert L. Shepard, Jin Cao, Advances in Enzyme Regulation Molecular PharmacologyPharmacological CharacterizationBiochemistryMedicineGlycobiology	1997	86
P‐glycoprotein Influences the Brain Concentrations of Cetirizine (Zyrtec®), a Second‐Generation Non‐Sedating Antihistamine Joseph W. Polli, Todd M. Baughman, Joan E. Humphreys, Journal of Pharmaceutical Sciences Second‐generation Non‐sedating AntihistamineNeurobiology Of DiseaseNeurophysiologyMedicineBrain Concentrations	2003	85
METABOLIC ACTIVATION OF PIOGLITAZONE IDENTIFIED FROM RAT AND HUMAN LIVER MICROSOMES AND FRESHLY ISOLATED HEPATOCYTES Todd M. Baughman, Rachel Graham, Kevin J. Wells‐Knecht, Drug Metabolism and Disposition	2005	41
Liquid chromatography/nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry identification of novel metabolites of the multidrug resistance modulator LY335979 in rat bile and human liver microsomal incubations. William J. Ehlhardt, Joseph M. Woodland, Todd M. Baughman, PubMed Metabolomic ProfilingMedicinal ChemistryNovel MetabolitesBioanalysisCompound Ly335979	1998	40
Determination of zanamivir in rat and monkey plasma by positive ion hydrophilic interaction chromatography (HILIC)/tandem mass spectrometry Todd M. Baughman, Wayne L. Wright, Kathryn A. Hutton Journal of Chromatography B Pharmacological StudyMedicineBioanalysisMass SpectrometryToxicology	2007	36
Design and synthesis of spirocyclic compounds as HCV replication inhibitors by targeting viral NS4B protein Vincent W.‐F. Tai, Dulce Garrido, Daniel J. Price, Bioorganic & Medicinal Chemistry Letters Synthetic VirologyMedicineDrug DiscoveryAntiviral Drug DevelopmentAntiviral Therapy	2014	28
THE SYSTEMIC EXPOSURE OF AN N-METHYL-d-ASPARTATE RECEPTOR ANTAGONIST IS LIMITED IN MICE BY THE P-GLYCOPROTEIN AND BREAST CANCER RESISTANCE PROTEIN EFFLUX TRANSPORTERS Joseph W. Polli, Todd M. Baughman, Joan E. Humphreys, Drug Metabolism and Disposition	2004	24
Synthesis and pharmacokinetic profile of highly deuterated brecanavir analogs Emile J. Velthuisen, Todd M. Baughman, Brian A. Johns, European Journal of Medicinal Chemistry MedicineAntiviral Drug DevelopmentBrecanavir AnalogsAntiviral DrugPharmacology	2013	20
Evaluation of the metabolism of propranolol by linear ion trap technology in mouse, rat, dog, monkey, and human cryopreserved hepatocytes Todd M. Baughman, Christine L. Talarico, John R. Soglia Rapid Communications in Mass Spectrometry	2009	18

Page 1